Value Creation · Healthcare / Medical Device / Digital Health

Market entry for a respiratory health-data startup: sizing a >$10B TAM

The challenge

Respiratory remote patient monitoring data startup with >$50M in equity financing needed help identifying growth opportunities in pulmonary disease treatment and pharma data monetization.

The solution

  • Sized total addressable market (TAM) of new and incumbent COPD treatment providers and hub services providers
  • Identified attractive market entry segments by analyzing >60 marketed products for COPD medical interventions (pricing, administration complexity for anticholinergic inhalers, beta-agonists, combination therapy, etc.)
  • Analyzed case studies of analogous real-world data usage in prospective studies to improve medication adherence
  • Created financial model (revenue build, operating costs, capital requirements) for new business unit

The impact

  • >$10B total addressable market identified
  • >60 products analyzed
  • Identified concrete pharma customer segments for market entry strategy

In their words

Ben was very diligent and thorough in his work. The project deliverable was on time and in satisfactory shape. He adapted well to changes in project scope and process. We would work with Ben again.
Partner, Boutique Healthcare Data Consultancy (via Catalant)

Back to all client impact


Start a conversation.

Get in touch to discover how Navis Advisory can help.